Merus to Participate in a Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference

Rhea-AI Summary

Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company, announced that CEO Bill Lundberg will participate in a fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on May 18 at 8:00 a.m. ET. The presentation will be available via a live webcast on the company's Investors page, with an archived version accessible for a limited time afterward.

Merus specializes in developing innovative multispecific antibodies, known as Biclonics® and Triclonics®, aiming to provide advanced therapeutic options in cancer treatment.

UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., Chief Executive Officer of Merus, will participate in a fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Tuesday, May 18 at 8:00 a.m. ET.

The live webcast of the presentation will be available on the Investors page of the Company's website. An archived presentation will be available on the Merus website for a limited time.

About Merus
Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For additional information, please visit Merus’ website and twitter.

FAQ

When will Merus participate in the RBC Capital Markets Global Healthcare Conference?

Merus will participate in the RBC Capital Markets Global Healthcare Conference on May 18, 2021, at 8:00 a.m. ET.

Who is presenting for Merus at the RBC conference?

Bill Lundberg, M.D., the CEO of Merus, will be presenting at the conference.

How can I watch the Merus presentation at the healthcare conference?

The presentation will be available through a live webcast on the Investors page of Merus' website.

What is the stock symbol for Merus?

The stock symbol for Merus is MRUS.

What type of products does Merus develop?

Merus develops innovative full-length multispecific antibodies, referred to as Biclonics® and Triclonics®.